If patients with established AF have an indication for long term OAC, the P2Y12 inhibitor of choice is usually clopidogrel, with the exception of patients at high ischaemic risk where ticagrelor or prasugrel might be considered. The gene discussed is P2RY12; the disease is atrial fibrillation.